The White House and the Department of Health and Human Services have announced the names of the first set of Part B prescription drugs that will be subject to Medicare inflation rebates because they raised their prices faster than inflation.
One of them is Humira, the AbbVie offering that treats arthritis. President Biden’s drug law includes checks to ensure that prescription drug companies have to pay back Medicare if they raise prices on seniors at a higher rate than inflation.
